Who founded Mercy BioAnalytics?

Mercy BioAnalytics was founded by Paul Blavin, Stanley Lapidus in 2018.

Who are Mercy BioAnalytics's investors?

Mercy BioAnalytics's investors include Avestria Ventures, Hatteras Venture Partners, iSelect Fund, Mindshift Capital, Novalis LifeSciences, Portfolia, Sozo Ventures, The Perkins Fund and 1 more.

How much funding has Mercy BioAnalytics raised?

Mercy BioAnalytics has disclosed $68.3M raised across 2 of its 4 known rounds.

Where is Mercy BioAnalytics headquartered?

Mercy BioAnalytics is headquartered in Natick, US.

Mercy BioAnalytics

Natick, US · Founded 2018 · 64 employees on LinkedIn · 9 known investors

Find your way into Mercy BioAnalytics

Each arrow is one introduction. Sign up to fill in the first one.

669 people can intro you to Stan

Ask Sangeeta N. Bhatia to introduce you to Stan Lapidus

You →Sangeeta · together at Amplifyer Bio →Stan

231 people can intro you to Paul

Ask Jamie Chen to introduce you to Paul Blavin

You →Jamie · together at Mercy BioAnalytics →Paul

Your email: who you already know at Mercy BioAnalytics, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Mercy BioAnalytics team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Mercy BioAnalytics develops diagnostic tests for early cancer detection using advanced proteomics and genomics technologies. The company serves healthcare providers and patients seeking to improve cancer detection accuracy and timing.

Biotech Digital Health Healthtech Medical Devices

Founders & leadership

Mercy BioAnalytics was founded in 2018 by Paul Blavin and Stanley Lapidus.

Paul Blavin Co-Founder & Vice ChairmanPaul Blavin is co-founder and Vice Chairman of Mercy BioAnalytics, which develops diagnostic tests for early cancer detection. He co-founded the Blavin Scholars in 2003, a nonprofit supporting individuals with foster care or homelessness experience in pursuing post-secondary education.

Stanley Lapidus Co-founder · Chairman, Board or DirectorsCEO, SynapDX & Founding Pillar at Pillar VC

Dawn Mattoon, PhDChief Executive Officer

Joseph SedlakExecutive

Board

Paul MeisterBoard directorPartner at Novalis LifeSciences

Sonja Hoel Perkins Board directorManaging Director at The Perkins Fund

Investors · 9

Avestria Ventureslisted by Avestria VenturesSan Francisco

How we know: Avestria Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Hatteras Venture Partnerslisted by Hatteras Venture PartnersResearch Triangle · $500K – $4M

How we know: Hatteras Venture Partners's portfolio page · Not right? Tell us

iSelect Fundlisted by iSelect FundSt. Louis · $250K – $2M

Mindshift Capitallisted by Mindshift CapitalDubai

Novalis LifeScienceslisted by Novalis LifeSciencesPortsmouth

How we know: board seat on SEC Form D · Not right? Tell us

Portfolialisted by PortfoliaSan Mateo

How we know: Portfolia's portfolio page · the VCSheet dataset · Not right? Tell us

Sozo Ventureslisted by Sozo VenturesRedwood City

How we know: Sozo Ventures's portfolio page · funding news · Not right? Tell us

The Perkins Fundlisted by The Perkins Fundvia Sonja Perkins · inferred

BrightEdgereportedAtlanta

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Funding

SEC filings, press & company announcements

$68.3M disclosed across 2 of 4 rounds · 2020–2025

Undisclosed amountSeries BSep 2025
Source ↗
Undisclosed amountSeries AApr 2023
Source ↗
$41MraisedApr 2023 · 2 sources
Source ↗

▶$27.3MraisedFeb 2021 · 57 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Paul BlavinExecutive Officer, Director
Joseph SedlakExecutive Officer, Director
Stanley LapidusDirector
Paul MeisterDirector
Sonja Hoel PerkinsDirector

Offering amount: $27.3M
Amount sold: $27.3M
First sale: Nov 2020
Incorporated: Corporation, Delaware, 2018
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through Mercy BioAnalytics went on to found or lead other companies.

Stan LapidusDirectorFounded Exact Sciences Myla Lai-GoldmanBoard MemberFounded GeneCentric Sarah KalilAdvisorFounded CoreMap

In the news

Mercy BioAnalytics Announces $59 Million Series B Financing to Advance Early Cancer Detection Programs - Mercy BioAnalyticsmercybio.com · Sep 2025

Mercy BioAnalytics Raises $41M in Series A Fundingfinsmes.com · Apr 2023

Frequently asked questions

What does Mercy BioAnalytics do?: Mercy BioAnalytics develops diagnostic tests for early cancer detection using advanced proteomics and genomics technologies. The company serves healthcare providers and patients seeking to improve cancer detection accuracy and timing.
Who founded Mercy BioAnalytics?: Mercy BioAnalytics was founded by Paul Blavin, Stanley Lapidus in 2018.
Who are Mercy BioAnalytics's investors?: Mercy BioAnalytics's investors include Avestria Ventures, Hatteras Venture Partners, iSelect Fund, Mindshift Capital, Novalis LifeSciences, Portfolia, Sozo Ventures, The Perkins Fund and 1 more.
How much funding has Mercy BioAnalytics raised?: Mercy BioAnalytics has disclosed $68.3M raised across 2 of its 4 known rounds.
Where is Mercy BioAnalytics headquartered?: Mercy BioAnalytics is headquartered in Natick, US.